Women across life stages

Estrogen and Skin Across the Female Lifespan: From Puberty to Your 60s, 70s and Beyond

Written by: Lindsey Walsh

|

Published on

|

Time to read 18 min

Your skin does not age in a straight line. It changes in response to the hormonal landscape of each life stage — sometimes dramatically, sometimes gradually, always meaningfully. The skin you had at 16 is not the skin you had at 35 or will have at 55 or 75. Understanding why requires understanding how estrogen — the hormone that defines the female lifespan — shapes skin biology at each stage of a woman's life.


This post follows that journey from the first hormonal surge of puberty through the decades that follow, covering what estrogen is doing to skin at each stage, what women typically experience, and what skincare approaches are most relevant. For the foundational science of how estrogen works in skin — its receptors, mechanisms, and comprehensive biological effects — see Estrogen and Skin: How It Works.

Puberty — The Estrogen Surge

Puberty represents the most dramatic hormonal transition of the female lifespan — a rapid escalation from the low, relatively stable hormone environment of childhood to the cycling, higher-estrogen environment of reproductive life.


What's happening hormonally: The hypothalamic-pituitary-gonadal axis activates, triggering ovarian estrogen production that rises from childhood levels of approximately 5-10 pg/mL to adult reproductive levels of 100-400 pg/mL across the menstrual cycle. Androgens — testosterone and DHEA from the adrenal glands and ovaries — also rise significantly, preceding the estrogen surge by 1-2 years in a phase called adrenarche. [1]


What skin experiences:

The androgenic surge of early puberty hits the skin before estrogen is fully established — producing the characteristic skin changes most associated with adolescence:

  • Increased sebum production — androgens stimulate sebaceous gland development and activity, producing the oilier skin texture that begins in early puberty. Sebaceous gland size increases dramatically under androgenic stimulation, and sebum production rises 4-5 fold. [2]
  • Acne — the combination of increased sebum, altered sebum composition, and the resulting changes in follicular environment creates conditions favorable to Cutibacterium acnes proliferation and the inflammatory cascade of acne. Acne affects up to 85% of adolescents to some degree, making it the most common skin condition of puberty.
  • Pore development — sebaceous gland enlargement makes pores more visible, particularly on the nose, forehead, and chin — the T-zone where sebaceous gland density is highest.
  • Skin thickening — rising estrogen stimulates collagen production and epidermal development, producing the thicker, more resilient skin that characterizes adult skin compared to child skin.
  • Body hair development — androgens stimulate the conversion of vellus (fine, unpigmented) body hairs to terminal (coarser, pigmented) hairs in androgen-sensitive areas.
  • Pigmentation changes — rising estrogen stimulates melanocyte activity, contributing to the nipple darkening and subtle overall pigmentation deepening that occurs in puberty.
  • What this means for skincare: Adolescent skin needs gentle cleansing that manages sebum without stripping the barrier, non-comedogenic moisturization, and targeted support for acne-prone areas. The barrier is newly mature and resilient but should not be over-treated with harsh actives designed for adult skin. [2]

The Reproductive Years — The Cycling Skin

The reproductive years — roughly 18-40 for most women — are characterized by the monthly rhythmic cycling of estrogen and progesterone that defines the menstrual cycle. Skin is responsive to these fluctuations in ways many women recognize but few have had explained.


The monthly skin cycle:

  • Follicular phase (days 1-14): Estrogen rises steadily from menstruation to ovulation. In the first half of this phase, skin may appear clearer as sebum production moderates and the anti-inflammatory effects of rising estrogen take hold. Skin often looks its best in the days immediately before ovulation when estrogen peaks — research suggests women's skin appears most luminous and symmetrical at this point in the cycle, consistent with the evolutionary biology of peak fertility signaling. [3]
  • Ovulation (day 14): The estrogen peak. Skin is typically at its most hydrated, firm, and clear. Collagen synthesis is maximally supported.
  • Luteal phase (days 15-28): Progesterone rises after ovulation, producing sebum-stimulating effects that can increase oiliness and pore size. In the late luteal phase, as both estrogen and progesterone fall before menstruation, skin often becomes more reactive, prone to breakouts, and sensitive. The premenstrual skin flare — breakouts, increased sensitivity, puffiness — is directly driven by this hormonal withdrawal. [3]
  • Menstruation (days 1-5): Estrogen and progesterone are at their lowest. Skin may be at its most sensitive and reactive. The inflammatory signaling of menstruation itself may contribute to increased skin reactivity.

What this means for skincare: Cycle-aware skincare — adapting routine intensity to hormonal phase — is increasingly supported by both science and the experiences of women who pay attention. Introducing stronger actives (retinoids, exfoliants, vitamin C) in the follicular phase when skin is more resilient, and backing off to more supportive, barrier-focused care in the late luteal phase, can improve both efficacy and tolerability.


Hormonal contraceptives: Oral contraceptive pills, patches, and other hormonal contraceptives significantly alter the skin's hormonal environment. Combined pills (estrogen + progestin) typically improve acne and reduce sebum through their anti-androgenic effects. Progestin-only methods have variable effects depending on the androgenicity of the specific progestin used — some improve skin, some worsen it. The skin changes associated with starting or stopping hormonal contraception are directly driven by the hormonal shifts they produce. [1]

Pregnancy — The High-Estrogen State

Pregnancy represents the highest estrogen exposure of the female lifespan — circulating estradiol levels in the third trimester are approximately 100 times higher than non-pregnant levels, with estriol (a weaker estrogen produced by the placenta) contributing additional estrogenic activity. [4]


What skin experiences:

  • The pregnancy glow — the combination of increased blood volume (40-50% more circulating blood by the third trimester), enhanced skin microcirculation driven by rising estrogen and progesterone, increased sebaceous activity, and hormonal stimulation of skin hydration produces the characteristic luminosity associated with healthy pregnancy. For many women, skin genuinely is better in the second trimester than at any other point in their lives.
  • Melasma (chloasma) — the "mask of pregnancy" affects up to 70% of pregnant women. High estrogen (and elevated MSH from the pituitary) dramatically upregulates melanocyte activity, producing the patchy brown hyperpigmentation that typically affects the cheeks, forehead, and upper lip. UV exposure significantly worsens melasma, making sun protection particularly important during pregnancy. [4]
  • Linea nigra — the dark vertical line that appears on the abdomen in most pregnancies reflects the same melanocyte-stimulating effects.
  • Stretch marks (striae gravidarum) — affect 50-90% of pregnant women. The rapid stretching of skin over the abdomen, breasts, and hips, combined with pregnancy hormones that alter collagen and elastin structure, produces the characteristic striae. Estrogen and relaxin (a pregnancy hormone) reduce the tensile strength of collagen, making skin more susceptible to stretch-induced damage. [4]
  • Acne changes — variable. The first trimester hormonal surge worsens acne for many women; the higher estrogen of the second trimester often improves it. Progesterone dominance in the third trimester can worsen sebum production again.
  • Increased skin sensitivity — many women experience heightened skin sensitivity and reactivity during pregnancy, attributed to immune system modulation and barrier changes.

What this means for skincare: Pregnancy requires significant reformulation of skincare routines — many conventional actives are contraindicated in pregnancy, including retinoids, salicylic acid at high concentrations, and certain chemical sunscreen filters. Vitamin C, niacinamide, hyaluronic acid, and physical sunscreens are generally considered safe. Melasma management focuses on consistent SPF use and gentle brightening actives like vitamin C and azelaic acid. [4]

Postpartum — The Estrogen Cliff

The postpartum period represents one of the most dramatic and rapid hormonal transitions of the female lifespan — estrogen levels that were 100 times normal during late pregnancy fall to below-normal levels within days of delivery, as the placenta (the primary source of pregnancy estrogens) is removed.


What skin experiences:

  • Telogen effluvium — the most universally recognized postpartum skin change. During pregnancy, elevated estrogen prolongs the anagen (growth) phase of hair follicles, reducing normal hair shedding. After delivery, the sudden estrogen withdrawal triggers a synchronized entry of these retained follicles into telogen, producing the diffuse hair shedding that typically peaks at 3-4 months postpartum. Up to 30% of hair can be shed in this period. The hair loss is self-limiting — follicles return to normal cycling as hormones stabilize — but the experience can be alarming. [5]
  • Barrier changes — the rapid estrogen withdrawal produces rapid changes in barrier function: reduced ceramide synthesis, increased transepidermal water loss, and increased skin sensitivity. Many women notice their skin becoming drier and more reactive in the weeks after delivery.
  • Melasma persistence — melasma that developed during pregnancy may fade as estrogen levels normalize, but it often persists and can be worsened by UV exposure, requiring ongoing management.
  • Acne flares — the postpartum hormonal shift can trigger acne in women who had clear skin during pregnancy, as the anti-androgenic buffering of pregnancy estrogens is removed and androgens become relatively dominant.
  • Breastfeeding effects — breastfeeding maintains suppressed estrogen levels through prolactin-mediated inhibition of ovulation. Women who breastfeed may experience prolonged versions of the postpartum skin changes — continued dryness, sensitivity, and barrier impairment — until weaning and the restoration of normal ovarian function.

What this means for skincare: The postpartum period calls for barrier-supportive, gentle skincare that addresses the rapid skin changes of estrogen withdrawal while accommodating the safety considerations of breastfeeding. Hyaluronic acid, ceramides, and gentle cleansing take priority. Hair support — biotin, gentle scalp care, and time — is the primary approach to postpartum telogen effluvium. [5]

Perimenopause — The Transition

Perimenopause — the transition from reproductive to post-reproductive hormonal status — typically begins in the mid-to-late 40s and lasts 2-10 years. It is characterized not by a smooth decline in estrogen but by erratic, unpredictable fluctuations — periods of very high estrogen alternating with periods of low estrogen — as the ovaries' follicular reserve depletes and hormonal regulation becomes increasingly inconsistent. [6]


What skin experiences:

  • Unpredictability — the hallmark of perimenopausal skin is inconsistency. Skin that behaves normally one week may be oily and breaking out the next, then dry and reactive the week after. This reflects the hormonal volatility of the perimenopausal transition rather than a stable new skin type.
  • The return of acne — adult-onset acne in the 40s and 50s is increasingly common and directly linked to perimenopausal hormonal fluctuations. As estrogen levels become erratic, the anti-androgenic buffering it provided becomes inconsistent — producing periods of relative androgenic dominance that drive sebaceous overactivity and acne flares. [6]
  • Beginning collagen loss — the first measurable accelerations in collagen loss begin in perimenopause as the average estrogen exposure over time begins to decline. Skin may begin to appear less firm and resilient.
  • Increased dryness and sensitivity — barrier function begins to show the effects of declining average estrogen levels, even as acute fluctuations continue. Many women notice their skin becoming less forgiving in perimenopause — more reactive to products it previously tolerated, drier despite the same moisturizing routine.
  • Vasomotor effects on skin — the hot flashes and night sweats of perimenopause produce repeated cycles of flushing and sweating that affect skin surface chemistry, microbiome composition, and, over time, barrier function. Women with rosacea often experience significant worsening during perimenopause for this reason.
  • Pigmentation changes — existing hyperpigmentation may deepen; new solar lentigines may appear as melanocyte regulation becomes less consistent.

What this means for skincare: Perimenopausal skin benefits from flexible routines that can adapt to hormonal fluctuations — barrier-supportive on dry days, oil-managing on oily days. Introducing collagen-supporting actives (retinoids, vitamin C, peptides) during perimenopause rather than waiting for menopause captures more of the collagen-protective window. Consistent SPF use becomes increasingly important as melanocyte regulation becomes less reliable. [6]

Menopause — The New Baseline

Menopause is defined as 12 consecutive months without a menstrual period — the point at which ovarian estrogen production has permanently ceased. The average age of natural menopause in the US is 51-52, though the range is broad (45-55 for most women). [7]


What skin experiences:

  • The collagen cliff — in the first five years after menopause, women lose approximately 30% of dermal collagen — a rate of approximately 2.1% per year, roughly twice the background age-related rate. This accelerated loss is directly attributable to estrogen withdrawal and produces a visible, rapid change in skin firmness and structure that many women find the most distressing skin change of their lives. [7]
  • Barrier impairment — ceramide synthesis declines with estrogen loss, producing increased transepidermal water loss, increased dryness, and reduced barrier resilience. Skin that was easily managed before menopause may suddenly feel perpetually dry, tight, and reactive.
  • Epidermal thinning — reduced keratinocyte proliferation produces a measurably thinner epidermis within years of menopause — contributing to increased fragility, slower healing, and greater vulnerability to UV damage.
  • Sebaceous changes — sebum production declines significantly, contributing to dryness and altered microbiome composition. Paradoxically, some women experience adult acne as the relative balance between estrogen and androgens shifts.
  • Pigmentation redistribution — existing hyperpigmentation may become more pronounced; skin tone becomes less even; overall luminosity decreases as melanocyte regulation loses its estrogenic support.
  • Wound healing slows — the estrogen-supported wound healing mechanisms described in the mechanisms post decline significantly, producing slower recovery from minor skin injuries and procedures.

What this means for skincare: Menopause represents the most significant pivot point in a woman's skincare life. Formulations that were adequate before may be insufficient after. Key priorities: ceramide supplementation for barrier repair, collagen-supporting actives (retinoids, vitamin C, copper peptides) to slow accelerated loss, richer emollients for barrier support, and consistent sun protection to prevent compounding photodamage on more vulnerable skin. [7]

Early Post-Menopause — The Reset (Years 1-10)

The first decade after menopause is a period of adaptation — skin adjusting to a new, lower hormonal baseline. The most dramatic changes occur in these years, and the skincare decisions made during this period have significant long-term consequences for skin health.


What skin experiences:

The changes of menopause continue and consolidate in the early post-menopausal years. Collagen loss, while still accelerated relative to pre-menopausal rates, begins to slow from its immediate post-menopausal peak as skin adapts to the new hormonal environment. The barrier, while compromised, begins to find a new equilibrium. [7]

  • Hormone replacement therapy (HRT): For women who choose HRT, the skin benefits are measurable and well-documented. Studies show HRT users maintain significantly higher skin collagen content, better barrier function, improved skin thickness, and reduced TEWL compared to non-users at comparable ages. The decision to use HRT involves considerations well beyond skin that are beyond the scope of this post — but the skin effects are unambiguously positive for those who use it appropriately. [8]
  • The window of opportunity: The collagen that is lost in the first post-menopausal decade cannot be fully recovered. Skincare interventions that support collagen synthesis and slow degradation are most impactful when started early in the post-menopausal period rather than years later. This is the decade in which retinoids, vitamin C, copper peptides, and consistent sun protection deliver their greatest relative return.

What this means for skincare: This is the period for building a comprehensive, active skincare routine — one that addresses barrier support, collagen synthesis, antioxidant protection, and consistent SPF simultaneously. The ingredients that support these functions — covered throughout the Juventude ingredient series — become the foundation of a routine designed for this hormonal reality. [8]

Thriving in Your 60s, 70s and Beyond — Skin's New Normal

Skin in the 60s, 70s, and beyond has adapted to its post-menopausal hormonal baseline. The dramatic fluctuations and rapid changes of the menopausal transition are behind it. What remains is skin with its own specific character — different from younger skin, but not deficient. It has its own needs, its own strengths, and responds well to skincare designed for what it actually is rather than what it used to be.


What skin is doing:

The hormonal drivers of the early post-menopausal years have largely stabilized. Skin changes in this phase are driven more by the accumulating effects of intrinsic aging, UV history, and general biological aging than by acute estrogen withdrawal. [9]

  • Skin becomes progressively thinner — the dermis and epidermis continue to thin gradually over the decades. By the 70s, skin may be 30-40% thinner than at reproductive age — more fragile, more transparent, and more prone to bruising from minor trauma.
  • Collagen continues to decline — at the slower background age-related rate rather than the accelerated post-menopausal rate. The collagen architecture becomes increasingly fragmented and disordered.
  • Sebaceous glands reduce further — sebum production continues to decline, producing skin that is often profoundly dry. The microbiome adapts to this drier environment but with reduced diversity.
  • Wound healing slows progressively — reduced growth hormone, reduced fibroblast activity, and reduced immune function contribute to progressively slower healing.
  • Vascular changes — reduced capillary density and vascular fragility produce paler skin and increased bruising tendency (senile purpura).
  • Reduced immune surveillance — Langerhans cell density continues to decline, reducing the skin's immune responsiveness — relevant both to infection risk and to the development of skin cancers. [9]

What thriving looks like in this phase:

The most important shift in this phase is from prevention to support — from trying to maintain younger skin to caring expertly for the skin you have. This means:

  • Rich, barrier-supportive formulations — this skin needs generous emolliency. Lightweight gels and watery serums designed for oilier younger skin are often insufficient. Occlusive and emollient-rich formulations that reduce TEWL and support the compromised barrier are essential.
  • Gentle actives at appropriate concentrations — retinoids remain beneficial but may need to be used at lower concentrations and less frequently than in younger skin. Vitamin C, peptides, and growth factors continue to support collagen maintenance. The goal is ongoing support rather than dramatic renewal.
  • Consistent, comprehensive sun protection — UV damage accumulates throughout life, and skin in this phase is less able to repair UV-induced damage. SPF is as important at 75 as at 35.
  • Avoiding barrier disruption — harsh cleansers, over-exfoliation, and high-alcohol products are more damaging in this phase because barrier repair is slower. Gentle is not a compromise — it is the correct approach.
  • Skincare as self-care — women in their 60s, 70s, and beyond are the most engaged, knowledgeable, and discerning skincare consumers. They deserve content and products that treat them as such — not as a market to be managed with anti-aging marketing, but as women with specific biological needs that well-formulated skincare can genuinely address. [9]

Premature Menopause — When the Transition Comes Early

For some women, menopause arrives years or decades earlier than expected — through surgery, medical treatment, or spontaneous premature ovarian insufficiency. This is a distinct and important category because premature estrogen withdrawal has more severe long-term consequences than natural menopause, and because the skin and health implications extend over a longer post-menopausal lifetime.

  • Surgical menopause — bilateral oophorectomy (removal of both ovaries) produces immediate, complete estrogen withdrawal within hours of surgery. Unlike natural menopause, which unfolds gradually over years of perimenopause, surgical menopause is abrupt — producing the full constellation of estrogen withdrawal symptoms simultaneously and rapidly. Skin changes that occur over years in natural menopause can appear within weeks.
  • Chemotherapy-induced premature menopause — alkylating agents and certain platinum-based chemotherapy regimens are gonadotoxic, causing premature ovarian failure in premenopausal women at rates of 40-68% depending on regimen and age. The younger the woman, the more years of estrogen exposure she loses — with proportionally greater long-term consequences for skin, bone, and cardiovascular health. [10]
  • GnRH agonist-induced menopause — used for ovarian suppression in premenopausal breast cancer treatment, GnRH agonists (leuprolide, goserelin) produce a reversible medical menopause. Skin changes during treatment mirror those of natural menopause; recovery occurs when treatment ends.
  • Premature ovarian insufficiency (POI) — spontaneous cessation or severe reduction of ovarian function before age 40, affecting approximately 1% of women. POI produces premature menopause with all of its skin consequences beginning in what should be the peak reproductive years.

What this means for skincare: Premature menopause at any age requires the same skincare adaptations as natural menopause — barrier support, collagen-active ingredients, rich emolliency — but beginning earlier and extending over a longer lifetime. For women experiencing chemotherapy-induced or treatment-related premature menopause, the skin changes compound the direct effects of treatment itself, creating a more complex skin environment that requires particularly thoughtful support. [10]

Supporting Skin at Every Stage

The hormonal journey of the female lifespan is not a story of inevitable decline — it is a story of change, adaptation, and the opportunity to respond intelligently to each new hormonal reality. A few principles that apply across stages:

  • Match your routine to your hormonal reality, not your age. A 45-year-old in perimenopause has different skin needs than a 45-year-old on high-dose oral contraceptives. A 58-year-old on HRT has different skin needs than a 58-year-old who is not. Chronological age is a proxy for hormonal status — the actual hormonal status is what matters.
  • Barrier support is foundational at every stage. From the sebum-rich oiliness of puberty to the ceramide-depleted dryness of post-menopause, barrier health underlies every other skin concern. Products and routines that protect and support the barrier are the most broadly applicable investment across all life stages.
  • Start collagen-supporting actives early. The collagen you maintain in your 30s and 40s is the collagen you will have less of in your 50s and 60s. Retinoids, vitamin C, sun protection, and collagen-supporting peptides deliver their greatest cumulative benefit when started before the accelerated loss phase of menopause.
  • Adapt as you transition. The single most important skincare decision at any hormonal transition — puberty, pregnancy, perimenopause, menopause — is recognizing that your previous routine may no longer serve your skin's new needs and being willing to reassess.

The Bottom Line

Estrogen shapes skin differently at every stage of the female lifespan — from the androgenic surge of puberty to the cycling rhythms of the reproductive years, the high-estrogen state of pregnancy, the rapid withdrawal of postpartum and menopause, and the adapted stability of later life. Each stage has its own hormonal signature, its own characteristic skin behaviors, and its own most relevant skincare priorities. Understanding where you are in this journey — and what your skin's hormonal environment is actually doing — transforms skincare from a generic routine into a responsive, life-stage-appropriate practice. The science is clear: estrogen is the most comprehensively skin-active hormone in women, and working with its rhythms rather than against them is the foundation of skin health across a lifetime.





Read More in the Series: Your Skin Through Every Stage - Women

This article is for educational purposes only and does not constitute medical advice. Consult with healthcare professionals before starting any new skincare regimen, especially if you have existing skin conditions or are undergoing medical treatment.

 

What To Read Next

Skincare 101: Why a Routine Works Better Than a Single Product


Why Hormones Matter — For Everyone: The Case for Hormonal Literacy


Image of Lindsey Walsh, Founder of Juventude

The Author: Lindsey Walsh

Lindsey is founder and CEO of Juventude. A breast cancer survivor and cancer advocate. Lindsey built Juventude to provide effective skin care based on antioxidant-rich plants and without endocrine disrupting toxins. 

Her Journal

References

  1. Zouboulis CC, et al. "Frontiers in sebaceous gland biology and pathology." Experimental Dermatology, 2008; 17(6):542-551. https://doi.org/10.1111/j.1600-0625.2008.00730.x
  2. Dreno B, et al. "Acne in adolescents." Journal of the European Academy of Dermatology and Venereology, 2020; 34(Suppl 2):3-10. https://doi.org/10.1111/jdv.16218
  3. Thornton MJ. "Oestrogens and ageing skin." Dermato-Endocrinology, 2013; 5(2):264-270. https://doi.org/10.4161/derm.23872
  4. Tunzi M, Gray GR. "Common skin conditions during pregnancy." American Family Physician, 2007; 75(2):211-218.
  5. Grover C, Khurana A. "Telogen effluvium." Indian Journal of Dermatology, Venereology and Leprology, 2013; 79(5):591-603. https://doi.org/10.4103/0378-6323.116731
  6. Greendale GA, et al. "The menopause transition." Endocrine Reviews, 1999; 20(4):449-477. https://doi.org/10.1210/edrv.20.4.0369
  7. Brincat M, et al. "Sex hormones and skin collagen content in postmenopausal women." British Medical Journal, 1983; 287(6402):1337-1338. https://doi.org/10.1136/bmj.287.6402.1337
  8. Verdier-Sevrain S. "Effect of estrogens on skin aging and the potential role of selective estrogen receptor modulators." Climacteric, 2007; 10(4):289-297. https://doi.org/10.1080/13697130701467157
  9. Farage MA, et al. "Characteristics of the aging skin." Advances in Wound Care, 2013; 2(1):5-10. https://doi.org/10.1089/wound.2011.0356
  10. Petrek JA, et al. "Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment." Journal of Clinical Oncology, 2006; 24(7):1045-1051. https://doi.org/10.1200/JCO.2005.03.3969